Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
about
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
@en
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
@nl
type
label
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
@en
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
@nl
prefLabel
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
@en
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
@nl
P2093
P2860
P1433
P1476
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
@en
P2093
Anders Sundström
Anna Borgenvik
Camilla U Persson
Holger Weishaupt
James E Bradner
Sara Bolin
William A Weiss
Yoon-Jae Cho
P2860
P2888
P304
P356
10.1038/S41388-018-0135-1
P407
P577
2018-03-07T00:00:00Z